CAD,Caspase激活的脫氧核糖核酸酶（抗原）產(chǎn)品詳情：
英文名稱：5730477D02Rik; CAD; Caldesmon; Caspase activated deoxyribonuclease; Caspase activated DNase; Caspase activated nuclease; Caspase-activated deoxyribonuclease; Caspase-activated DNase; Caspase-activated nuclease; CDM; CPAN; Deoxyribonuclease III, caspase activated; DFF 40; DFF-40; DFF2; DFF40; Dffb; DFFB_HUMAN; Didff; DNA fragmentation factor 40 kDa subunit; DNA fragmentation factor subunit beta; DNA fragmentation factor, 40 Da, beta polypeptide (caspase activated DNase); DNA fragmentation factor, 40 kD beta subunit; DNA fragmentation factor, 40 kD, beta polypeptide; DNA fragmentation factor, 40kDa, beta polypeptide (caspase activated DNase); DNA fragmentation factor, 40kDa, beta polypeptide (caspase-activated DNase); DNAation factor, beta subunit; OTTHUMP00000003633
中文名稱：Caspase 激活的脫氧核糖核酸酶（抗原）
產(chǎn)品編號：byk-0043P
規(guī) 格：0.5mg
多肽活性：
產(chǎn)品來源：
分 類：
偶聯(lián)蛋白：
純化方法：
儲 存 液：0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
CAD,Caspase激活的脫氧核糖核酸酶（抗原）其他優(yōu)質(zhì)產(chǎn)品：
人低分子肝素(LMWH)試劑盒說明書，96T/48T優(yōu)質(zhì)
人抗肝細(xì)胞膜抗體(LMA)試劑盒說明書，96T/48T優(yōu)質(zhì)
人抗肝腎微粒體抗體(LKM)試劑盒說明書，96T/48T優(yōu)質(zhì)
人抗肝素PF4復(fù)合物抗體/HIT抗體(HIT)試劑盒說明書，96T/48T優(yōu)質(zhì)
人抗可溶性肝抗原抗體(SLA)試劑盒說明書，96T/48T優(yōu)質(zhì)
人游離脂肪酸(FFA)試劑盒說明書，96T/48T優(yōu)質(zhì)
人顆粒酶B(Gzms-B)試劑盒說明書，96T/48T優(yōu)質(zhì)
人顆粒酶A(Gzms-A)試劑盒說明書，96T/48T優(yōu)質(zhì)
人丙二醛(MDA)試劑盒說明書，96T/48T優(yōu)質(zhì)
人葡萄糖依賴性胰島素釋放多肽(GIP)試劑盒說明書，96T/48T優(yōu)質(zhì)
保存條件：Store at -20 °C for one year. The lyophilized powder is stable at room temperature for at least one month and for greater than a year when kept at -20°C. Upon reconstituted, aliquot and store at -20°C or -80°C. Avoid repeated freeze/thaw cycles.
產(chǎn)品介紹：Carbamoyl phosphate synthetase-aspartate carbamoyltransferase-dihydroorotase (CAD) is a multifunctional protein that initiates and regulates mammalian de novo pyrimidine biosynthesis. This trifunctional protein which is associated with the enzymatic activities of the first 3 enzymes in the 6-step pathway of pyrimidine biosynthesis is the rate-limiting step in the de novo pyrimidine synthetic pathway. Although most of the CAD protein in the cell is cytosolic, phosphorylation at threonine 456 localizes the protein to the nucleus. While MAPK and EGF phosphorylate CAD at threonine 456, MAPK and c-myc have been found to induce over-expression of CAD
相關(guān)產(chǎn)品：
Anti-MKP-1/DUSP1(Mitogen activated protein kinase phosphatase 1) 絲裂原活化蛋白激酶磷酸酶-1抗體
Anti-MKP-2/DUSP4(Mitogen activated protein kinase phosphatase 2) 絲裂原活化蛋白激酶磷酸酶-2抗體
Anti-ER-α（Estrpgen Receptor alpha） 雌激素受體α抗體
Anti-ER/PR/c-erbB-2 Kit(mouse monoclonal) ER/PR/c-erbB-2檢測試劑盒（鼠單抗）
Anti-phospho-ER-α(pSer167)human 抗人磷酸化雌激素受體α抗體
Anti-phospho-ER-α（pTyr537）mouse ret 抗人、大、小鼠、牛、犬磷酸化雌激素受體α抗體
Anti-ER-α（Estrpgen Receptor alpha） 雌激素受體α抗體（用于westen blot）
Anti-ER-α（Estrpgen Receptor alpha） 雌激素受體α抗體
Anti-ER-α/β Estrpgen Receptor α/β 雌激素受體α/β抗體
Anti-ER-β (Estrogen receptor-β) 雌激素受體β 抗體
會員1.png)
